Reference : Towards a European strategy to address the COVID-19 pandemic
Scientific journals : Article
Life sciences : Multidisciplinary, general & others
Human health sciences : Immunology & infectious disease
Human health sciences : Multidisciplinary, general & others
Systems Biomedicine
http://hdl.handle.net/10993/47800
Towards a European strategy to address the COVID-19 pandemic
English
Priesemann, V. [> >]
Balling, Rudolf [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) >]
Bauer, S. []
Beutels, P. [> >]
Valdez, A. C. [> >]
Cuschieri, S. [> >]
Czypionka, T. [> >]
Dumpis, U. [> >]
Glaab, Enrico mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Biomedical Data Science]
Grill, E. [> >]
Hotulainen, P. [> >]
Iftekhar, E. N. [> >]
Krutzinna, J. [> >]
Lionis, C. [> >]
Machado, H. [> >]
Martins, C. [> >]
McKee, M. [> >]
Pavlakis, G. N. [> >]
Perc, M. [> >]
Petelos, E. [> >]
Pickersgill, M. [> >]
Prainsack, B. [> >]
Schernhammer, E. [> >]
Szczurek, E. [> >]
Tsiodras, S. [> >]
Van Gucht, S. [> >]
Willeit, P. [> >]
In press
The Lancet
Yes
International
[en] COVID-19 ; SARS-CoV-2 ; expert survey ; Delphi study ; group forecast ; non-pharmaceutical interventions
[en] How will the coronavirus disease 2019 (COVID-19) pandemic develop in the coming months and years? Based on an expert survey, we examine key aspects that are likely to influence the COVID-19 pandemic in Europe. The challenges and developments will strongly depend on the progress of national and global vaccination programs, the emergence and spread of variants of concern (VOCs), and public responses to non-pharmaceutical interventions (NPIs). In the short term, many people remain unvaccinated, VOCs continue to emerge and spread, and mobility and population mixing are expected to increase. Therefore, lifting restrictions too much and too early risk another damaging wave. This challenge remains despite the reduced opportunities for transmission given vaccination progress and reduced indoor mixing in summer 2021. In autumn 2021, increased indoor activity might accelerate the spread again, whilst a necessary reintroduction of NPIs might be too slow. The incidence may strongly rise again, possibly filling intensive care units, if vaccination levels are not high enough. A moderate, adaptive level of NPIs will thus remain necessary. These epidemiological aspects combined with economic, social, and health-related consequences provide a more holistic perspective on the future of the COVID-19 pandemic.
Luxembourg Centre for Systems Biomedicine (LCSB): Biomedical Data Science (Glaab Group)
Fonds National de la Recherche - FnR
CovScreen > Combined In Silico Molecular Docking And In Vitro Experimental Assessment Of Drug Repurposing Candidates For Covid-19 > 01/06/2020 > 30/11/2020 > 2020
Researchers ; Professionals ; Students
http://hdl.handle.net/10993/47800
10.1016/S0140-6736(21)01808-0
https://doi.org/10.1016/S0140-6736(21)01808-0
The original publication is available at https://doi.org/10.1016/S0140-6736(21)01808-0
in press
FnR ; FNR14715687 > Enrico Glaab > CovScreen > Combined In Silico Molecular Docking And In Vitro Experimental Assessment Of Drug Repurposing Candidates For Covid-19 > 01/06/2020 > 30/11/2020 > 2020

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
PIIS0140673621018080.pdfPublisher postprint55.73 kBView/Open

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.